Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (436)
Listed medicine compliance report (15)

Date

2025 (38)
2024 (31)
2023 (14)
2022 (42)
2021 (42)
2020 (64)
2019 (58)
2018 (97)
2017 (16)
2016 (8)
2015 (41)

Search

Sponsor content

451 result(s) found, displaying 231 to 240

Cenovis Triplus 50+ (Multivitamin + Mineral + Omega 3) Blister Cancelled under Section 30(1)(c) of the Act

16 January 2020

Cancellation by sponsor

Requested by Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
BUSCOPAN hyoscine butylbromide 10mg suppository strip pack Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
BUSCOPAN hyoscine butylbromide 10mg tablet tube Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
BISOLVON DRY KIDS dextromethorphan hydrobromide monohydrate 2mg/mL oral liquid bottle Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Cenovis Triplus Men Cancelled under Section 30(1)(c) of the Act

18 November 2019

Cancellation by sponsor

Requested by Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Cenovis Triplus Women Cancelled under Section 30(1)(c) of the Act

18 November 2019

Cancellation by sponsor

Requested by Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
CHILDREN'S TIXYLIX DRY COUGH & COLD 2 YRS+ oral liquid bottle Cancelled under Section 30(1)(c) of the Act

7 November 2019

Cancellation by sponsor

Requested by Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
CHILDREN'S TIXYLIX NIGHT COUGH & COLD 2 YRS+ oral liquid bottle Cancelled under Section 30(1)(c) of the Act

7 November 2019

Cancellation by sponsor

Requested by Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
CHILDREN'S TIXYLIX CHEST RUB ESSENTIAL OILS 1YR+ ointment tube Cancelled under Section 30(1)(c) of the Act

7 November 2019

Cancellation by sponsor

Requested by Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
CHILDREN'S TIXYLIX CHESTY COUGH & COLD 2YRS+ oral liquid bottle Cancelled under Section 30(1)(c) of the Act

7 November 2019

Cancellation by sponsor

Requested by Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

Pages

First page
Previous page
…
Page 20
Page 21
Page 22
Page 23
Current page 24
Page 25
Page 26
Page 27
Page 28
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.